Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05852470 · ClinicalTrials.gov registry record · NA
Evaluation of Clareon Vivity/Vivity Toric
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 155
- Enrollment target
NCT05852470 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 155 participants.
The verdict
NCT05852470, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 155 participants
- Enrollment target
Study Summary
This study seeks to generate clinical data from subjects previously implanted with the Clareon Vivity/Vivity Toric Intraocular Lenses (IOLs) or Clareon Monofocal/Clareon Toric IOLs. This study will assess key performance endpoints to support clinical benefits statements with model-specific data.
Interventions
- DEVICE Clareon Vivity/Vivity Toric Extended Vision IOL
- DEVICE Clareon Monofocal/Clareon Toric IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2023-05-23 |
| Est. Completion | 2023-10-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05852470
The ClinicalTrials.gov registry entry for NCT05852470 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Clareon Vivity/Vivity Toric Extended Vision IOL is the first listed.
NCT05852470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05852470 about?
NCT05852470 is a clinical study titled "Evaluation of Clareon Vivity/Vivity Toric". This study seeks to generate clinical data from subjects previously implanted with the Clareon Vivity/Vivity Toric Intraocular Lenses (IOLs) or Clareon Monofocal/Clareon Toric IOLs. This study will assess key performance endpoints to support clinical benefits statements with model-specific data.
What is the current status of trial NCT05852470?
This trial is currently completed. It is a NA study. The enrollment target is 155 participants. The study started on 2023-05-23. Estimated completion is 2023-10-27.
What interventions are being tested in trial NCT05852470?
The interventions under investigation include: Clareon Vivity/Vivity Toric Extended Vision IOL (DEVICE), Clareon Monofocal/Clareon Toric IOL (DEVICE).
Who is sponsoring clinical trial NCT05852470?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.